Coarctation of the aorta: nonsurgical treatment using stent implantation

H L Ang, C W Lim, C Hia

  • 1Division of Cardiology, Department of Paediatrics, National University of Singapore, Lower Kent Ridge Road, Singapore. swee _chye _quek@nuhs.edu.sg.

Insights

Nonsurgical treatment using aortic coarctation (CoA) stenting in adults offers a less invasive alternative to surgery. This study shows good outcomes with significant pressure gradient reduction and no complications in four patients.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Vascular Surgery

Background:

  • Coarctation of the aorta (CoA) is a congenital heart defect affecting 5%-8% of patients.
  • Untreated significant CoA leads to severe morbidity and potential mortality.
  • Surgical repair is the traditional treatment for CoA.

Purpose of the Study:

  • To evaluate the efficacy of aortic coarctation (CoA) stenting as a nonsurgical treatment option.
  • To present the treatment outcomes of adult patients who underwent CoA stenting.
  • To explore a potential new treatment paradigm for CoA.

Main Methods:

  • Retrospective review of four adult patients (20-41 years) with native CoA or restenosis.
  • CoA stenting performed under general anaesthesia using Palmaz or Cheatham-Platinum stents.
  • Pre- and post-procedure angiography and pressure gradient measurements.

Main Results:

  • Successful stenting with significant reduction in pressure gradients across the coarctation site.
  • Angiography confirmed relief of the aortic narrowing.
  • Follow-up for 1-3 years revealed no reported complications.

Conclusions:

  • Aortic coarctation (CoA) stenting is an effective nonsurgical treatment for adult patients.
  • This less invasive approach demonstrates promising outcomes and safety.
  • Catheter-based stenting may represent a paradigm shift in CoA management.
Abstract

Related Concept Videos

Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
478
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
583
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
511
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
442
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
653
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
719